ArticleHIV/AIDS (Auckland, N.Z.)2019

Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential.

Cristina Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.